{"count":10,"index":{"built_at":"2026-07-27T21:07:39.313434+00:00","public_records":55311,"revision":"aea9bdf6cb0e11a47b427849"},"query":{"area":null,"kind":null,"lang":null,"limit":10,"match_mode":"all_terms","q":"Myths vs Facts: LDL und menopause"},"results":[{"answer":"Menopause and LDL: separating myths from facts. Fact: LDL cholesterol typically rises after menopause due to declining estrogen, which normally enhances hepatic LDL receptor activity. This leads to reduced clearance and higher circulating LDL. Myth: All LDL is equally harmful. In reality, small dense LDL particles are more atherogenic than large buoyant ones. Another myth: Diet alone can fully counteract the postmenopausal LDL rise. While a heart-healthy diet helps, it rarely restores premenopausal levels. Myth: Every postmenopausal woman needs a statin. Treatment decisions should be based on global cardiovascular risk assessment, not just LDL numbers. Evidence: The link between menopause and LDL increase is human-strong (large cohort studies, mechanistic data). LDL subfraction analysis is human-moderate. Caveat: Genetic factors (e.g., APOE, PCSK9) and lifestyle (exercise, smoking) modify the effect. No specific sources from the provided context.","area":"gesundheit","canonical_id":"gesundheit:canonical-ff36ee0d58e8049d2147ffbb","id":"public-285f4e20d8af6adbe20e4d8d","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Myths vs facts: LDL and menopause","score":28.93931456,"snippet":"Menopause and LDL: separating myths from facts. Fact: LDL cholesterol typically rises after menopause due to declining estrogen, which normally enhances hepatic LDL receptor activity. This leads to reduced clearance and higher circulating LDL. Myth: All LDL is equally harmful. In reality, small dense LDL particles are more atherogenic than large buoyant ones. Another myth: Diet alone can fully counteract the postmenopausal LDL rise. While a heart-healthy diet helps, it rarely restores premenopausal levels. Myth: Every postmenopausal woman needs a statin. Treatment decisions should be based on global cardiovascular risk assessment, not just LDL numbers. Evidence: The link between menopause an","sources":[],"title":"Myths vs facts: LDL and menopause","url":"https://tikki.wiki/wissen/gesundheit/frage/public-285f4e20d8af6adbe20e4d8d/myths-vs-facts-ldl-and-menopause/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"Die Wechseljahre führen zu einem Absinken des Östrogenspiegels, was den LDL-Cholesterinspiegel oft ansteigen lässt. Dies ist ein physiologischer Vorgang, kein Mythos. Allerdings wird der Anstieg häufig überschätzt: Die durchschnittliche Zunahme liegt bei etwa 10–15 %, nicht bei 50 % oder mehr. Zudem verschiebt sich die LDL-Partikelgröße hin zu kleineren, dichteren Partikeln, die atherogener sind. Wichtig: LDL allein ist nicht der alleinige Risikofaktor – das Verhältnis zu HDL, Triglyceriden und Entzündungsmarkern (z. B. hs-CRP) ist entscheidend. Viele Frauen glauben, dass eine Hormonersatztherapie (HRT) LDL zwangsläufig senkt; tatsächlich hängt die Wirkung von Art, Dosis und Applikationsweg ab. Orale Östrogene senken LDL oft, können aber Triglyceride erhöhen. Transdermale Östrogene haben weniger Effekt auf Lipide. Lebensstilmaßnahmen (Ernährung, Bewegung) sind nachweislich wirksamer als die meisten Nahrungsergänzungsmittel. Die Evidenz basiert auf großen Beobachtungsstudien und randomisierten kontrollierten Studien (RCTs) zu HRT. Caveat: Viele DTC-Tests bieten „LDL-Genetik“ an, deren prädiktiver Wert gering ist.","area":"gesundheit","canonical_id":"gesundheit:canonical-b2430a87e87979dd2b3c337c","id":"public-2eafc7850cafd4ee4de08985","kind":"qa","language":"de","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Myths vs Facts: LDL und menopause","score":28.63886077,"snippet":"Die Wechseljahre führen zu einem Absinken des Östrogenspiegels, was den LDL-Cholesterinspiegel oft ansteigen lässt. Dies ist ein physiologischer Vorgang, kein Mythos. Allerdings wird der Anstieg häufig überschätzt: Die durchschnittliche Zunahme liegt bei etwa 10–15 %, nicht bei 50 % oder mehr. Zudem verschiebt sich die LDL-Partikelgröße hin zu kleineren, dichteren Partikeln, die atherogener sind. Wichtig: LDL allein ist nicht der alleinige Risikofaktor – das Verhältnis zu HDL, Triglyceriden und Entzündungsmarkern (z. B. hs-CRP) ist entscheidend. Viele Frauen glauben, dass eine Hormonersatztherapie (HRT) LDL zwangsläufig senkt; tatsächlich hängt die Wirkung von Art, Dosis und Applikationsweg ","sources":[],"title":"Myths vs Facts: LDL und menopause","url":"https://tikki.wiki/wissen/gesundheit/frage/public-2eafc7850cafd4ee4de08985/myths-vs-facts-ldl-und-menopause/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"Nein, die FOXO3-Variante (rs2764264) ist in Beobachtungsstudien und GWAS mit Langlebigkeit assoziiert, aber es gibt keinen direkten Nachweis, dass sie das LDL-Cholesterin oder das Herz-Kreislauf-Risiko senkt. Die Evidenz ist moderat und basiert auf populationsgenetischen Daten, nicht auf randomisierten Studien. Ein einzelner SNP kann andere Risikofaktoren wie Ernährung, Bewegung, Rauchen oder genetische Veranlagung für hohes LDL nicht aufheben. Hohe LDL-Werte sind ein etablierter kardiovaskulärer Risikofaktor, der unabhängig von dieser Variante behandelt werden sollte. Ignorieren Sie hohe LDL-Werte nicht; konsultieren Sie einen Arzt für eine umfassende Risikobewertung inklusive Lipidscreening und Lebensstiloptimierung. Die FOXO3-Variante ist kein Freibrief für riskantes Verhalten.","area":"gesundheit","canonical_id":"gesundheit:canonical-77610443cca20a69399ad3f6","id":"public-973a84fe1316d2144f49f0c9","kind":"qa","language":"de","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Myths vs Facts: Zink und menopause","score":28.5390577,"snippet":"Nein, die FOXO3-Variante (rs2764264) ist in Beobachtungsstudien und GWAS mit Langlebigkeit assoziiert, aber es gibt keinen direkten Nachweis, dass sie das LDL-Cholesterin oder das Herz-Kreislauf-Risiko senkt. Die Evidenz ist moderat und basiert auf populationsgenetischen Daten, nicht auf randomisierten Studien. Ein einzelner SNP kann andere Risikofaktoren wie Ernährung, Bewegung, Rauchen oder genetische Veranlagung für hohes LDL nicht aufheben. Hohe LDL-Werte sind ein etablierter kardiovaskulärer Risikofaktor, der unabhängig von dieser Variante behandelt werden sollte. Ignorieren Sie hohe LDL-Werte nicht; konsultieren Sie einen Arzt für eine umfassende Risikobewertung inklusive Lipidscreenin","sources":[],"title":"Myths vs Facts: Zink und menopause","url":"https://tikki.wiki/wissen/gesundheit/frage/public-973a84fe1316d2144f49f0c9/myths-vs-facts-zink-und-menopause/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"Myths vs facts about LDL and menopause: A common myth is that LDL cholesterol is inherently 'bad' and that menopause inevitably leads to cardiovascular disease. The fact is that LDL is essential for transporting fats and fat-soluble vitamins. During menopause, estrogen levels drop, which can increase LDL cholesterol and decrease HDL cholesterol – a natural but individually variable process. However, the size and density of LDL particles matter: small, dense LDL particles are more atherogenic than large, buoyant ones. A simple LDL number alone is a poor predictor of cardiovascular risk. Genetics, diet, exercise, and stress also significantly influence lipid metabolism. Direct-to-consumer tests, such as those from MyBody-X, typically measure total LDL but not particle subtypes or related factors like insulin resistance. The evidence for focusing solely on LDL during menopause is mixed: while hormonal changes do raise LDL, its predictive value for individual events is limited. Be cautious of marketing that frames LDL as the sole risk factor. A comprehensive assessment including triglycerides, HDL, inflammatory markers, and lifestyle is more informative. This answer is based on general medical knowledge, not on specific studies from the provided context.","area":"gesundheit","canonical_id":"gesundheit:canonical-6b1cbc07a4c161d8b244ac2f","id":"public-c3babae90015859ce9ad0aee","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Myths vs facts: LDL and Wechseljahre","score":28.53783925,"snippet":"Myths vs facts about LDL and menopause: A common myth is that LDL cholesterol is inherently 'bad' and that menopause inevitably leads to cardiovascular disease. The fact is that LDL is essential for transporting fats and fat-soluble vitamins. During menopause, estrogen levels drop, which can increase LDL cholesterol and decrease HDL cholesterol – a natural but individually variable process. However, the size and density of LDL particles matter: small, dense LDL particles are more atherogenic than large, buoyant ones. A simple LDL number alone is a poor predictor of cardiovascular risk. Genetics, diet, exercise, and stress also significantly influence lipid metabolism. Direct-to-consumer test","sources":[],"title":"Myths vs facts: LDL and Wechseljahre","url":"https://tikki.wiki/wissen/gesundheit/frage/public-c3babae90015859ce9ad0aee/myths-vs-facts-ldl-and-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"ApoB (apolipoprotein B) is a direct measure of the number of atherogenic particles (LDL, VLDL, IDL) and is considered a more precise risk marker than LDL cholesterol alone. Myth: 'After menopause, only LDL rises; ApoB stays the same.' Fact: The estrogen decline in menopause leads to an increase in small, dense LDL particles, which are particularly atherogenic. Since each such particle carries one ApoB molecule, ApoB often rises more than LDL-C. Another myth: 'ApoB is only relevant for men.' Fact: Women have lower ApoB before menopause, but after menopause the risk converges – ApoB is a strong predictor in both sexes. Myth: 'A normal LDL level rules out high risk.' Fact: With normal LDL, ApoB can be elevated (discordant hyperlipidemia), especially in metabolic syndrome or insulin resistance, which become more common during menopause. Evidence comes from large prospective studies and meta-analyses (e.g., Emerging Risk Factors Collaboration). Caveat: ApoB alone does not replace comprehensive risk stratification (including Lp(a), hsCRP, blood pressure, family history). A physician should interpret values in context. Evidence: human-moderate (strong observational data, but no RCTs proving ApoB as sole therapeutic target).","area":"gesundheit","canonical_id":"gesundheit:canonical-0a0623f1943e22e7e2286b6b","id":"public-7839c0218df6f4aeb24b10b9","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Myths vs facts: ApoB and menopause","score":28.4516484,"snippet":"ApoB (apolipoprotein B) is a direct measure of the number of atherogenic particles (LDL, VLDL, IDL) and is considered a more precise risk marker than LDL cholesterol alone. Myth: 'After menopause, only LDL rises; ApoB stays the same.' Fact: The estrogen decline in menopause leads to an increase in small, dense LDL particles, which are particularly atherogenic. Since each such particle carries one ApoB molecule, ApoB often rises more than LDL-C. Another myth: 'ApoB is only relevant for men.' Fact: Women have lower ApoB before menopause, but after menopause the risk converges – ApoB is a strong predictor in both sexes. Myth: 'A normal LDL level rules out high risk.' Fact: With normal LDL, ApoB","sources":[],"title":"Myths vs facts: ApoB and menopause","url":"https://tikki.wiki/wissen/gesundheit/frage/public-7839c0218df6f4aeb24b10b9/myths-vs-facts-apob-and-menopause/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"Mythos: ApoB sei nur für Männer relevant oder zeige bei Frauen vor der Menopause keine Aussagekraft. Fakt: ApoB ist ein direktes Maß für die Anzahl atherogener Lipoproteine und gilt als präziserer Risikomarker als LDL-Cholesterin, insbesondere bei Frauen nach der Menopause. Der Östrogenabfall führt zu einem Anstieg der LDL-Partikelzahl und damit des ApoB-Spiegels, auch wenn das LDL-Cholesterin noch im Normbereich liegt. Viele Frauen und Ärzte übersehen diesen Effekt, da Standard-Lipidpanels oft nur LDL-C messen. Ein erhöhtes ApoB nach der Menopause ist ein unabhängiger Risikofaktor für kardiovaskuläre Ereignisse. Die Evidenz stammt aus epidemiologischen Studien und Leitlinien (z. B. ESC/EAS), jedoch nicht aus dem bereitgestellten Kontext. Caveat: Einzelne Messungen können schwanken; ApoB sollte im Kontext von Lebensstil, Ernährung und anderen Risikofaktoren interpretiert werden. Ein Test allein ersetzt keine ärztliche Beratung. Für Frauen in der Perimenopause kann die Bestimmung von ApoB helfen, frühzeitig präventive Maßnahmen wie Ernährungsumstellung oder Bewegung zu ergreifen.","area":"gesundheit","canonical_id":"gesundheit:canonical-6e49b3840d12f2a7f34c1037","id":"public-7dfe4adf43555a155caacb74","kind":"qa","language":"de","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Myths vs Facts: ApoB und menopause","score":28.3491721,"snippet":"Mythos: ApoB sei nur für Männer relevant oder zeige bei Frauen vor der Menopause keine Aussagekraft. Fakt: ApoB ist ein direktes Maß für die Anzahl atherogener Lipoproteine und gilt als präziserer Risikomarker als LDL-Cholesterin, insbesondere bei Frauen nach der Menopause. Der Östrogenabfall führt zu einem Anstieg der LDL-Partikelzahl und damit des ApoB-Spiegels, auch wenn das LDL-Cholesterin noch im Normbereich liegt. Viele Frauen und Ärzte übersehen diesen Effekt, da Standard-Lipidpanels oft nur LDL-C messen. Ein erhöhtes ApoB nach der Menopause ist ein unabhängiger Risikofaktor für kardiovaskuläre Ereignisse. Die Evidenz stammt aus epidemiologischen Studien und Leitlinien (z. B. ESC/EAS)","sources":[],"title":"Myths vs Facts: ApoB und menopause","url":"https://tikki.wiki/wissen/gesundheit/frage/public-7dfe4adf43555a155caacb74/myths-vs-facts-apob-und-menopause/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"ApoB (Apolipoprotein B) ist ein zentraler Bestandteil atherogener Lipoproteine und gilt als präziserer Risikomarker für Herz-Kreislauf-Erkrankungen als LDL-Cholesterin allein. In den Wechseljahren sinkt der Östrogenspiegel, was zu einem Anstieg von LDL und ApoB sowie zu einer Verschiebung hin zu kleineren, dichteren LDL-Partikeln führt – ein besonders atherogenes Profil. Ein verbreiteter Mythos ist, dass Cholesterinwerte nach der Menopause weniger relevant seien oder dass Frauen vor Herz-Kreislauf-Erkrankungen geschützt seien. Tatsächlich steigt das Risiko nach der Menopause deutlich an, und die Messung von ApoB kann helfen, dieses Risiko besser zu erfassen als LDL allein. Die Evidenz basiert auf großen prospektiven Studien und Metaanalysen, die ApoB als überlegenen Marker bestätigen. Dennoch wird ApoB in der klinischen Routine noch nicht flächendeckend eingesetzt. Eine individuelle Risikobewertung sollte immer im ärztlichen Kontext erfolgen, inklusive Lebensstilfaktoren und weiterer Laborwerte.","area":"gesundheit","canonical_id":"gesundheit:canonical-9115dc291b1e1ab25bdedf30","id":"public-5d75fe7ae46747a5a5bdb608","kind":"qa","language":"de","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Myths vs Facts: ApoB und Wechseljahre","score":27.88899675,"snippet":"ApoB (Apolipoprotein B) ist ein zentraler Bestandteil atherogener Lipoproteine und gilt als präziserer Risikomarker für Herz-Kreislauf-Erkrankungen als LDL-Cholesterin allein. In den Wechseljahren sinkt der Östrogenspiegel, was zu einem Anstieg von LDL und ApoB sowie zu einer Verschiebung hin zu kleineren, dichteren LDL-Partikeln führt – ein besonders atherogenes Profil. Ein verbreiteter Mythos ist, dass Cholesterinwerte nach der Menopause weniger relevant seien oder dass Frauen vor Herz-Kreislauf-Erkrankungen geschützt seien. Tatsächlich steigt das Risiko nach der Menopause deutlich an, und die Messung von ApoB kann helfen, dieses Risiko besser zu erfassen als LDL allein. Die Evidenz basier","sources":[],"title":"Myths vs Facts: ApoB und Wechseljahre","url":"https://tikki.wiki/wissen/gesundheit/frage/public-5d75fe7ae46747a5a5bdb608/myths-vs-facts-apob-und-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"Menopause alters lipid profiles, but HDL myths persist. A common myth is that high HDL always protects against heart disease. In reality, HDL levels often drop during menopause while LDL rises, increasing cardiovascular risk. However, HDL function (e.g., cholesterol efflux capacity) may matter more than its concentration. Some evidence suggests that postmenopausal HDL can become dysfunctional, losing its protective properties. The evidence is mostly observational and mixed; no large trials prove that raising HDL alone reduces risk. Lifestyle factors (diet, exercise, hormone therapy) have stronger effects. A DNA or blood test for HDL alone is insufficient; comprehensive lipid panels and clinical context are needed. Beware of marketing that oversimplifies HDL as a universal 'good' cholesterol.","area":"gesundheit","canonical_id":"gesundheit:canonical-f875202914d0cd262b30cffd","id":"public-af701cc453aa8719580fdc40","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Myths vs facts: HDL and menopause","score":27.32865091,"snippet":"Menopause alters lipid profiles, but HDL myths persist. A common myth is that high HDL always protects against heart disease. In reality, HDL levels often drop during menopause while LDL rises, increasing cardiovascular risk. However, HDL function (e.g., cholesterol efflux capacity) may matter more than its concentration. Some evidence suggests that postmenopausal HDL can become dysfunctional, losing its protective properties. The evidence is mostly observational and mixed; no large trials prove that raising HDL alone reduces risk. Lifestyle factors (diet, exercise, hormone therapy) have stronger effects. A DNA or blood test for HDL alone is insufficient; comprehensive lipid panels and clini","sources":[],"title":"Myths vs facts: HDL and menopause","url":"https://tikki.wiki/wissen/gesundheit/frage/public-af701cc453aa8719580fdc40/myths-vs-facts-hdl-and-menopause/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"Myth: 'ApoB is only relevant for men.' Fact: After menopause, women's cardiovascular risk rises sharply, and ApoB is a key marker. Estrogen enhances LDL receptor activity and clearance of ApoB-containing lipoproteins. With estrogen decline, LDL-C and especially ApoB increase, often surpassing levels in age-matched men. Myth: 'ApoB is just another way to measure LDL-C.' Fact: ApoB counts all atherogenic particles (LDL, VLDL, IDL, Lp(a)), while LDL-C only measures cholesterol mass. In menopausal women with small, dense LDL, LDL-C may appear normal despite elevated ApoB. Myth: 'ApoB testing is unnecessary if standard lipids are normal.' Fact: ApoB is an independent risk factor and can be elevated even when LDL-C is normal. Guidelines increasingly recommend ApoB as a treatment target for cardiovascular prevention, especially in postmenopausal women. Caveat: A single measurement is not diagnostic; lifestyle, diet, and family history matter. Evidence is strong (prospective studies, meta-analyses), but not everyone benefits equally from ApoB reduction.","area":"gesundheit","canonical_id":"gesundheit:canonical-68bac86bde976e3677ad0378","id":"public-4880a098b75b5c454ad187b4","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Myths vs facts: ApoB and Wechseljahre","score":27.27202929,"snippet":"Myth: 'ApoB is only relevant for men.' Fact: After menopause, women's cardiovascular risk rises sharply, and ApoB is a key marker. Estrogen enhances LDL receptor activity and clearance of ApoB-containing lipoproteins. With estrogen decline, LDL-C and especially ApoB increase, often surpassing levels in age-matched men. Myth: 'ApoB is just another way to measure LDL-C.' Fact: ApoB counts all atherogenic particles (LDL, VLDL, IDL, Lp(a)), while LDL-C only measures cholesterol mass. In menopausal women with small, dense LDL, LDL-C may appear normal despite elevated ApoB. Myth: 'ApoB testing is unnecessary if standard lipids are normal.' Fact: ApoB is an independent risk factor and can be elevat","sources":[],"title":"Myths vs facts: ApoB and Wechseljahre","url":"https://tikki.wiki/wissen/gesundheit/frage/public-4880a098b75b5c454ad187b4/myths-vs-facts-apob-and-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The APOA2 gene encodes apolipoprotein A-II, a component of HDL metabolism. During menopause, declining estrogen alters lipid profiles, often raising LDL and changing HDL. Some studies suggest that APOA2 variants may modestly influence weight gain or lipid changes in menopause, but the evidence is weak and inconsistent. Direct-to-consumer tests like MyBody-X analyze APOA2, but results are not diagnostic and lack clinical validation for menopause management. Fact: Lifestyle factors (diet, exercise) have a far greater impact on cardiovascular risk during menopause than single gene variants. Myth: APOA2 determines whether you will gain weight in menopause – this is not supported by strong evidence. Genetics provide only a small piece of the puzzle; hormone status, age, and lifestyle are key. Beware of exaggerated marketing claims.","area":"gesundheit","canonical_id":"gesundheit:canonical-757fd07bb28b58033a281a86","id":"public-bb1839f4586af448d884d1e2","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Myths vs facts: APOA2 and Wechseljahre","score":27.084955,"snippet":"The APOA2 gene encodes apolipoprotein A-II, a component of HDL metabolism. During menopause, declining estrogen alters lipid profiles, often raising LDL and changing HDL. Some studies suggest that APOA2 variants may modestly influence weight gain or lipid changes in menopause, but the evidence is weak and inconsistent. Direct-to-consumer tests like MyBody-X analyze APOA2, but results are not diagnostic and lack clinical validation for menopause management. Fact: Lifestyle factors (diet, exercise) have a far greater impact on cardiovascular risk during menopause than single gene variants. Myth: APOA2 determines whether you will gain weight in menopause – this is not supported by strong eviden","sources":[],"title":"Myths vs facts: APOA2 and Wechseljahre","url":"https://tikki.wiki/wissen/gesundheit/frage/public-bb1839f4586af448d884d1e2/myths-vs-facts-apoa2-and-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}}],"schema_version":"tikki.search-response.v1"}